Phoebe Mounts - 01 Nov 2021 Form 4 Insider Report for CorMedix Inc. (CRMD)

Role
General Counsel
Signature
/s/ Phoebe Mounts
Issuer symbol
CRMD
Transactions as of
01 Nov 2021
Net transactions value
+$100,000
Form type
4
Filing time
03 Nov 2021, 19:52:24 UTC
Next filing
23 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CRMD Common Stock 7,200 01 Nov 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRMD Stock Option (Right to Buy Common Stock) Award $100,000 100,000 01 Nov 2021 Common Stock 100,000 $5.56 Direct F1
holding CRMD Stock Option (Right to Buy Common Stock) 140,000 01 Nov 2021 Common Stock 140,000 $8.32 Direct F2
holding CRMD Stock Option (Right to Buy Common Stock) 50,000 01 Nov 2021 Common Stock 50,000 $5.63 Direct F3
holding CRMD Stock Option (Right to Buy Common Stock) 50,000 01 Nov 2021 Common Stock 50,000 $4.08 Direct F3
holding CRMD Stock Option (Right to Buy Common Stock) 24,764 01 Nov 2021 Common Stock 24,764 $5.63 Direct F4
holding CRMD Stock Option (Right to Buy Common Stock) 70,000 01 Nov 2021 Common Stock 70,000 $7.92 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options were granted on 11/1/2021. These options vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.
F2 These options were granted on 1/11/2021. These options vest, subject to continued employment, as follows: 50% of the options vest over time, with 25% vested on the grant date and 25% vesting in equal thirds on the first, second and third anniversaries of the grant date; and 50% of the options vest upon the achievement of certain milestones.
F3 These options were granted on 05/11/2020. These options vest 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.
F4 These options were granted on 02/25/2020. These options vest 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.
F5 The options vest as follows: 42,000 vest in equal fourths on May 1 of each of 2020, 2021, 2022 and 2023 and 28,000 vest upon the achievement of designated milestones.

Remarks:

The Issuer effected a 1-for-5 reverse stock split of its common stock on March 26, 2019. All share and per share exercise price amounts shown in this Form 4 have been adjusted to reflect the reverse stock split.